The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Marine Potez
No Relationships to Disclose
 
Justin Miller
Employment - Merck
 
Isaac Calle-Toral
No Relationships to Disclose
 
Firas Hatoum
No Relationships to Disclose
 
Johannes Ali
No Relationships to Disclose
 
Nicholas Couchara
No Relationships to Disclose
 
Jeffrey Johnson
No Relationships to Disclose
 
Christopher Guske
No Relationships to Disclose
 
Gowtam Mannam
No Relationships to Disclose
 
Shari Pilon-Thomas
Consulting or Advisory Role - KSQ Therapeutics; Morphogenesis, Inc.
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Dyve Biosciences (Inst); Intellia Therapeutics (Inst); Iovance Biotherapeutics (Inst); Provectus (Inst); Turnstone Bio (Inst)
Patents, Royalties, Other Intellectual Property - IP licensed from Moffitt to Tuhura. (Inst); Moffitt Cancer Center has licensed Intellectual Property related to the proliferation and expansion of tumor infiltrating lymphocytes (TILs) to Iovance Biotherapeutics. Shari Pilon-Thomas is an inventor on such Intellectual Property. (Inst); Patent with Provectus (Inst)
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer
Research Funding - AB Science (Inst); Allogene Therapeutics (Inst); Exelixis (Inst); Merck (Inst); Pfizer (Inst); Xilio Therapeutics (Inst)